Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 2
1949 1
1950 1
1952 1
1954 2
1955 2
1957 2
1958 5
1959 3
1960 4
1961 1
1962 3
1963 6
1964 21
1965 49
1966 215
1967 434
1968 565
1969 788
1970 937
1971 1060
1972 1229
1973 1451
1974 1522
1975 1625
1976 1851
1977 1813
1978 1823
1979 2094
1980 2139
1981 2283
1982 2443
1983 2509
1984 2612
1985 2735
1986 2456
1987 2418
1988 2405
1989 2408
1990 2377
1991 2207
1992 2087
1993 1940
1994 1724
1995 1803
1996 1811
1997 1788
1998 1789
1999 1931
2000 2019
2001 2022
2002 2013
2003 2163
2004 2177
2005 2196
2006 2355
2007 2342
2008 2276
2009 2269
2010 2356
2011 2320
2012 2337
2013 2366
2014 2430
2015 2309
2016 2179
2017 2029
2018 2042
2019 1980
2020 1989
2021 1931
2022 1763
2023 1747
2024 1798
2025 1923
2026 761

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

111,860 results

Results by year

Filters applied: . Clear all
Page 1
Beta-Blockers: Current State of Knowledge and Perspectives.
Ogrodowczyk M, Dettlaff K, Jelinska A. Ogrodowczyk M, et al. Mini Rev Med Chem. 2016;16(1):40-54. doi: 10.2174/1389557515666151016125948. Mini Rev Med Chem. 2016. PMID: 26471965 Review.
The structure, function, pharmacokinetics, and mechanism of beta-blockers have been established. The possibilities for their use in treating different conditions continue to evolve. Since the discovery of later generation beta-blockers, such as carvedi …
The structure, function, pharmacokinetics, and mechanism of beta-blockers have been established. The possibilities for their u …
Three Generations of beta-blockers: History, Class Differences and Clinical Applicability.
do Vale GT, Ceron CS, Gonzaga NA, Simplicio JA, Padovan JC. do Vale GT, et al. Curr Hypertens Rev. 2019;15(1):22-31. doi: 10.2174/1573402114666180918102735. Curr Hypertens Rev. 2019. PMID: 30227820 Review.
Antagonists of beta-adrenergic receptors, known as beta-blockers, have been used effectively for over four decades and have beneficial effects in the treatment of cardiovascular diseases. There are three generations of beta-blockers accor …
Antagonists of beta-adrenergic receptors, known as beta-blockers, have been used effectively for over four decad …
beta-blockers: Their new life from hypertension to cancer and migraine.
Fumagalli C, Maurizi N, Marchionni N, Fornasari D. Fumagalli C, et al. Pharmacol Res. 2020 Jan;151:104587. doi: 10.1016/j.phrs.2019.104587. Epub 2019 Dec 3. Pharmacol Res. 2020. PMID: 31809852 Free article. Review.
However, in specific niche of patients, such as in those young individuals in which hypertension is mainly driven by a sympathetic hyperactivation, strong evidence pose beta-Blockers as a highly reasonable first-line treatment. Lipophilic beta-blockers …
However, in specific niche of patients, such as in those young individuals in which hypertension is mainly driven by a sympathetic hyperacti …
Misconceptions and Facts About Beta-Blockers.
Argulian E, Bangalore S, Messerli FH. Argulian E, et al. Am J Med. 2019 Jul;132(7):816-819. doi: 10.1016/j.amjmed.2019.01.039. Epub 2019 Feb 25. Am J Med. 2019. PMID: 30817899 Review.
Beta-blockers are commonly used medications, and they have been traditionally considered "cardioprotective." ...On the other hand, the use of beta-blockers in uncomplicated hypertension results in suboptimal outcomes compared to the established first-l …
Beta-blockers are commonly used medications, and they have been traditionally considered "cardioprotective." ...On the other h …
[Beta-blockers : myths and facts].
Gay Des Combes Gliven P, Girod G, Petignat PA, Gobin N. Gay Des Combes Gliven P, et al. Rev Med Suisse. 2019 Sep 4;15(661):1566-1571. Rev Med Suisse. 2019. PMID: 31496190 Review. French.
Beta-blockers are very commonly drugs used in clinical practice, but whose mechanisms and clinical impacts are not always well understood, especially in certain specific clinical situations. This article proposes a review of some pharmacology notions over the differ …
Beta-blockers are very commonly drugs used in clinical practice, but whose mechanisms and clinical impacts are not always well …
Beta-blockers.
Louis WJ, Louis SN, Krum H. Louis WJ, et al. Med J Aust. 1994 Nov 7;161(9):555-7. doi: 10.5694/j.1326-5377.1994.tb127604.x. Med J Aust. 1994. PMID: 7968760 Review. No abstract available.
Beta-blockers.
Nicholls C, Sani M. Nicholls C, et al. Nurs Older People. 2004 Sep;16(6):35-7. doi: 10.7748/nop2004.09.16.6.35.c2330. Nurs Older People. 2004. PMID: 15470846 Review. No abstract available.
Beta-blockers in anxiety disorders.
Hayes PE, Schulz SC. Hayes PE, et al. J Affect Disord. 1987 Sep-Oct;13(2):119-30. doi: 10.1016/0165-0327(87)90017-6. J Affect Disord. 1987. PMID: 2890677 Review.
Studies evaluating the antianxiety and antipanic properties of beta-blockers do not support their routine use in treating either generalized anxiety disorder or panic disorder. ...Propranolol may provide symptomatic relief in some patients with residual somatic comp …
Studies evaluating the antianxiety and antipanic properties of beta-blockers do not support their routine use in treating eith …
[Update on beta blockers in 2020].
Bejan-Angoulvant T, Angoulvant D. Bejan-Angoulvant T, et al. Rev Med Interne. 2020 Nov;41(11):741-747. doi: 10.1016/j.revmed.2020.04.007. Epub 2020 Jun 10. Rev Med Interne. 2020. PMID: 32532560 Review. French.
Beta-blockers (BB) are an heterogenous set of molecules actively blocking beta adrenergic receptors. Their pharmacological properties depend on their various effects on the adrenergic signalling. Although they are no longer a first-choice treatm …
Beta-blockers (BB) are an heterogenous set of molecules actively blocking beta adrenergic receptors. Their pharm …
Beta-blockers in COPD: A systematic review based on recent research.
Li XF, Mao YM. Li XF, et al. Life Sci. 2020 Jul 1;252:117649. doi: 10.1016/j.lfs.2020.117649. Epub 2020 Apr 7. Life Sci. 2020. PMID: 32275936
Due to fear of exacerbating airway spasm, beta-blockers are rarely used in such patients. Many observational studies suggest that beta-blockers can reduce the disease progression and the risk of mortality in patients with COPD, but lack of confirmation …
Due to fear of exacerbating airway spasm, beta-blockers are rarely used in such patients. Many observational studies suggest t …
111,860 results
You have reached the last available page of results. Please see the User Guide for more information.